Prevention of post-operative deep leg vein thrombosis in patients with cancer

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 126-132

  Gallus, A S ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CERTOPARIN; DALTEPARIN; DANAPAROID; ENOXAPARIN; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; TINZAPARIN;

CANCER; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; GASTROCNEMIUS MUSCLE; HUMAN; LEG COMPRESSION; LEG THROMBOSIS; MEDICAL AUDIT; META ANALYSIS; MUSCLE EXCITATION; NEUROSURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOSIS PREVENTION;

EID: 0030805609     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657514     Document Type: Conference Paper

References (67)

1. Clagett GP, Anderson FA, Heit J, Levine MN. Prevention of venous tromboembolism. Chest 1995; 108 (Supplement):312S-33S.
2. Naschitz JE, Yeshurun D, Eldar S, Lev LM. Diagnosis of cancer-associated vascular disorders. Cancer 1966; 77:1759-67.
3. Prandoni P. Deep vein thrombosis and occult cancer. Ann Med 1993; 25:447-50.
4. Nordström M, Lindblad B, Anderson H, Bergqvist D, Kjellström T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994; 308:891-4.
5. Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Callejas JM, Martorell A. Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer 1991; 67:541-5.
6. Monreal M, Casals A, Boix J, Olazabal A, Montserrat E, Mundo MR. Occult cancer in patients with acute pulmonary embolism. A systematic approach. Chest 1993; 103:816-9.
7. Giuntini C, DiRicco G, Marino C, Melillo E, Palla A. Epidemiology. Chest 1995; 107 (Supplement):3S-9S.
8. Prandoni P, Lensing AWA, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7.
9. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983; 62:14-31.
10. Donati MB. Cancer and thrombosis:from phlegmasia alba dolens to transgenic mice. Thromb Haemos 1995; 74:278-81.
11. Falanga A, Ofusu FA, Cortellazzo S, Delaini F, Consonni R, Caccia R, Longatti S, Maran D, Rodighiero F, Pogliani E, Marassi A, D'Angelo A, Barbui T. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery. Brit J Haematol 1993; 85:745-50.
12. Sporn JR, Rickles FR. Coagulation abnormalities in cancer patients: clinical relevance. Chest 1994; 105:1639.
13. Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RCN. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346:1004-5.
14. Zuckerman E, Toubi E, Dov Golan E, Rosenvald-Zuckerman T, Sabo E, Shmuel Z, Yeshurun D. Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy. Brit J Cancer 1995; 72:447-51.
15. Shen VS, Pollak EW. Fatal pulmonary embolism in cancer patients. Southern Med J 1980; 73:841-3.
16. Svendsen E, Karwinski B. Prevalence of pulmonary embolism at necropsy in patients with cancer. J Clin Pathol 1989; 42:805-9.
17. Dhami MS, Bona RD, Calogero JA, Hellman RM. Venous thromboembolism and high grade gliomas. Thromb Haemos 1993; 70:393-6.
18. Kakkar VV, Howe CT, Nicolaides AN, Renney JTG, Clarke MB. Deep vein thrombosis of the leg. Is there a "high risk" group. Am J Surg 1970; 120:527-30.
19. Walsh JJ, Bonnar J, Wright FW. A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning. J Obs Gynae Brit Comm 1974; 81:311-6.
20. Brandjes DPM, ten Cate JW, Buller HR. Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively. Acta Chir Scand 1990; 556 (Suppl): 18-21.
21. Törngren S, Hägglund G, Molin K, Rieger Å. Postoperative deep venous thrombosis and infectious complications. Clinical study of patients undergoing colo-rectal surgery. Scand J Infect Dis 1980; 12:123-7.
22. Clarke-Pearson DL, DeLong ER, Syrian IS, Coleman RE, Creasman WT. Variables associated with postoperative deep venous thrombosis:a prospective study of 411 gynecology patients and creation of a prognostic model. Obstet Gynecol 1987; 69: 146-50.
23. Heatley RV, Hughes LE, Morgan A, Okwonga W. Preopertive or postoperative deep-vein thrombosis? Lancet 1976; 1:437-9.
24. Rodzynek JJ, Damien J, Huberty M, Abranovicz C, Garcez JL, Govaerts JP. Incidence of pre-operative deep venous thrombosis in abdominal surgery. Br J Surg 1984; 71:731-2.
25. Clagett PG, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of a meta-analysis. Ann Surg 1988; 208:227-40.
26. Rem J, Duckert F, Fridrich R, Gruber UF. Subkutane kleine Heparindosen zur Thromboseprophylaxe in der allgemeinen Chirurgie und Urologie. Schweiz med Wschr 1975; 105:827-35.
27. Gallus AS, Hirsh J, O'Brien SE, McBride JA, Tuttle RJ, Gent M. Prevention of venous thrombosis with small subcutaneous doses of heparin. JAMA 1976; 235:1980-2.
28. Törngren S. Optimal regimen of low-dose heparin prophylaxis in gastrointestinal surgery. Acta Chir Scand 1979; 145:87-93.
29. Cade JF, Clegg EA, Westlake GW. Prophylaxis of venous thrombosis after major thoracic surgery. Aust N Z J Surg 1983; 53:301-4.
30. Bergqvist D, Burmark US, Frisell J, Hallböök T, Lindblad B, Risberg B, Törngren S, Wallin G. Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg 1986; 73:204-8.
31. Bergqvist D, Mätzsch T, Burmark US, Frisell J, Guilbaud O, Hallböök T, Horn A, Ljungnér H, Ljungström K-G, Onarheim H, Risberg B, Törngren S, Örtenwall P. Low molecular weight heparin given the evening before surgery compared with conventional low dose heparin in the prevention of thrombosis. Br J Surg 1988; 75:888-91.
32. Samama M, Bernard P, Bonnardot JP, Combe-Tamzali S, Lanson Y, Tissot E. Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis. Br J Surg 1988; 75:128-31.
33. Liezorovicz A, Picolet H, Peyrieux JC, Bissel JP. Prevention of postoperative deep vein thrombosis in general surgery:a multicentre double-blind study comparing two doses of logiparin and standard heparin. Be J Surg 1991; 78:412-6.
34. Boneu B. An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Blood Coag Fibrinolysis 1993; 4 (Suppl): S21-2.
35. Caen JP. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in genral surgery. Thromb Haemos 1988; 59:216-20.
36. The European Fraxiparin Study (EFS) Group. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 1988; 75:1058-63.
37. Koppenhagen K, Adolf J, Matthes M, Tröster E, Roder JD, Haas S, Fritsche HM, Wolf H. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery. Thromb Haemos 1992; 67:627-30.
38. Gallus A, Cade J, Ockelford P, Hepburn S, Maas M, Magnani H, Bucknall T, Stevens J, Porteous F. Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised multicentre comparison. Thromb Haemos 1993; 70:562-7.
39. Nurmohamed MT, Herhaege R, Haas S, Iriarte JA, Vogel G, van Rij AM, Prentice CRM, ten Cate JW. A comparative trial of a low molecular weight heparin (Enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 1995; 169:567-71.
40. Bergqvist D, Burmark US, Flordal PA, Frisell J, Hallböök T, Hedberg M, Horn A, Kelty E, Kvitting P, Lindhagen A, Ljungström K-G, Mätzsch T, Risberg B, Syk I, Törngren S, Wellander E, Örtenwall P. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995; 82: 496-501.
41. Ockelford PA, Patterson J, Johns AS. A double-blind randomised placebo controlled trial of thromboprophylaxis in major elective general surgery using once daily injections of a low molecular weight heparin fragment (Fragmin). Thromb Haemos 1989; 62: 1046-9.
42. Kakkar VJ, Cohen AT, Edmondson RA, Phillips MJ, Cooper DJ, Das SK, Maher KT, Sanderson RM, Ward VP, Kakkar S. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341:259-65.
43. Rosenberg IL, Evans M, Pollock AV. Prophylaxis of post-operative leg vein thrombosis with low dose subcutaneous heparin or peroperative calf muscle stimulation:a controlled randomised trial. BMJ 1975; 1:649-51.
44. Lindström B, Holmdahl C, Jonsson O, Korsan-Bengtsen K, Lindberg S, Petrusson B, Pettersson S, Wikstrand J, Wojciechowski J. Prediction and prophylaxis of postoperative thromboembolism - a comparison between peroperative calf muscle stimulation with groups of impulses and dextran 40. Br J Surg 1982; 69:633-7.
45. Allan A, Williams JT, Bolton JP, Le Quesne LP. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 1983; 70:172-4.
46. Roberts VC, Cotton LT. Prevention of postoperative deep vein thrombosis in patients with malignant disease. BMJ 1974; 1: 358-60.
47. Cisek LJ, Walsh PC. Thromboembolic complications following radical retropubic prostatectomy. Urology 1993; 42:406-8.
48. Turpie AGG, Gallus AS, Beattie WS, Hirsh J. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology 1977; 27:435-48.
49. Turpie AGG, Delmore T, Hirsh J, Hull R, Genton E, Hiscoe C, Gent M. Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease. Thromb Res 1979; 15:611-6.
50. Turpie AGG, Hirsh J, Gent M, Julian D, Johnson J. Prevention of deep vein thrombosis in neurosurgical patients. Arch Intern Med 1989; 149:679-81.
51. Nurmohamed MT, van Riel AM, Henkens CMA, Koopman MMW, Que GTH, d'Azemar P, Büller HR, ten Cate JW, Hoek JA, van der Meer J, van den Heul C, Turpie AGG, Haley S, Sicurella J, Gent M. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemos 1996; 75:223-8.
52. Clarke-Pearson DL, Coleman RE, Synan IS, Hinshaw W, Creasman WT. Venous thromboembolism prophylaxis in gynecologic oncology:a prospective controlled trial of low-dose heparin. An J Obstet Gynecol 1983; 145:606-13.
53. Clarke-Pearson DL, Synan IS, Hinshaw W, Coleman RE, Creasman WT. Prevention of postoperative venous thromboembolism by extrenal pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 1984; 63:92-8.
54. Clarke-Pearson DL, Creasman WT, Coleman RE, Synan IS, Hinshaw W. Perioperative extrenal pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial. Gynecol Oncol 1984; 18:226-32.
55. Clarke-Pearson DL, DeLong E, Synan IS, Soper JT, Creasman WT, Coleman RE. A controlled trial of two low-dose heprin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol 1990; 75:684-9.
56. Clarke-Pearson DL, Synan IS, Dodge R, Soper JT, Berchuk A, Coleman RE. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol 1993; 168:1146-54.
57. Huber O, Bounameux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127:310-3.
58. Rasmussen MS, Wille-Jørgensen P, Jorgensen LN. Postoperative fatal pulmonary embolism in a general surgical department. Am J Surg 1995; 169:214-6.
59. Collaborative Group on Heparin Prophylaxis in Surgery (SEPEC). Is there still an avoidable fraction of pot-operative thromboembolic complications with heparin prophylaxis? The results of a case-control surveillance. J Clin Epidemiol 1993; 46:371-7.
60. Wille-Jørgensen P, Ott P. Predicting failure of low-dose prophylactic heparin in general surgical procedures. Surg Gynec Obstet 1990; 171:126-30.
61. Veth G, Meuwissen OJATh, van Houwelingen HC, Sixma JJ. Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone. Thromb Haemos 1985; 54:570-3.
62. Kakkar VV, Murray WJG. Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism:a co-operative study. Br J Surg 1985; 72: 786-91.
63. Flordal PA, Bergqvist D, Ljungström K-G, Törngren S. Clinical relevance of the fibrinogen uptake test in patients having general abdominal surgery - relation to major thromboembolism and mortality. Thromb Res 1995; 80:491-7.
64. The Venous Thromboembolism Study Group of the Spanish Society of Clinical Pharmacology. Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. Br J clin Pharmac 1994; 37:255-9.
65. Avery CM, Jamieson NV, Calne RY. Administration of heparin and antibiotic prophylaxis. Brit J Surg 1994; 81:987-8.
66. Avery CM, Jamieson NV, Calne RY. Effective administration of heparin and antibiotic prophylaxis. Brit J Surg 1995; 82:1136-7.
67. Comerota AJ, Katz ML, White JV. Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg 1992; 164:265-8.